Drug Manufacturers - Specialty & Generic | Healthcare
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.
Market Cap
1617563392
Current Price
101.6
52 Week Range
78.06 - 157.98
Previous Close
101.01
Open
101.0
Sector
Healthcare
Address
Lakshmi Narayan Complex, 5th Floor 10/1, Palace Road, Bengaluru, 560052, India
Phone
+91-80413-79500
Fax
+91-80223-54057
Website
https://www.balpharma.com
Day Low
100.5
Day High
101.99
Dividend Yield
1.19
PE Ratio
22.231947
Earnings Per Share
4.57
Beta
0.199
EBITDA
295599008
Book Value
39.087
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Shailesh Dheerajmal Siroya | MD & Executive Director | 58 | 1966 |
Mr. Daddanala Venkat Bharath Bhushan | Chief Financial Officer | 35 | 1989 |
Mr. Abdul Basith | Company Secretary & Compliance Officer | - | - |
Mr. Himesh Virupakshaya | Whole Time Director | 63 | 1961 |
Mr. Ravindra Kumar Kothari | Deputy GM of Internal Audit, Legal and Compliances & Non-Executive and Non-Independent Director | 69 | 1955 |
Mr. D. L. Bhat | Assistant Vice President of Sales & Marketing | 61 | 1963 |
Ms. Archana Dubey Mitra | Vice President of International Marketing & HR | 50 | 1974 |
Mr. Kotian Chittananda Damodar | Whole Time Director | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.